Abstract: Every year, there are more than 32 million acute and chronic tendon and ligament injuries that occur in the United States. Due to the limited healing ability of tendons, many of these injuries require the use of a graft for recovery. These grafts are usually created from material taken from another location in the patient's body, synthetic polymers, or from decellularized tissue taken from cadavers. More often than not, these methods are problematic suffering from limited supply, threat of infection, and donor site morbidity. Another major problem facing tendon regeneration is the failure of grafts 6–12 months after implantation, which leads to pain, graft rejection, and the need for subsequent surgery. Tendon tissue engineering aims to alleviate these issues by creating viable tendon grafts that utilize the patient's own cells as the building blocks for new tissue.
Publication Year: 2015
Publication Date: 2015-01-01
Language: en
Type: book-chapter
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot